Following Its 52-Week Low, Revance Therapeutics Inc (NASDAQ: RVNC)’S Share Price Fall -7.6% And Its YTD Numbers Fell -62.57%
During the last session, Revance Therapeutics Inc (NASDAQ:RVNC)’s traded shares were 2.64 million, with the beta value of the company hitting 1.15. At the end